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Abstract Oligosaccharides of glycoproteins expressed
on the cell surface play important roles in cell-cell
interactions, particularly sialylated N-glycans having a
negative charge, which interact with sialic acid-binding
immunoglobulin-like lectins (siglecs). The entire struc-
ture of sialylated N-glycans expressed in the mouse
brain, particularly the linkage type of sialic acid resi-
dues attached to the backbone N-glycans, has not yet
been elucidated. An improved method to analyze
pyridylaminated sugar chains using high performance
liquid chromatography (HPLC) was developed to deter-
mine the entire structure of sialylated N-linked sugar
chains expressed in the adult and developing mouse
cerebral cortices. Three classes of sialylated sugar
chains were prevalent: 1) N-glycans containing α(2-3)-
sialyl linkages on a type 2 antennary (Galβ(1-
4)GlcNAc), 2) sialylated N-glycans with α(2-6)-sialyl
linkages on a type 2 antennary, and 3) a branched
sialylated N-glycan with a [Galβ(1-3){NeuAcα(2-
6)}GlcNAc-] structure, which was absent at embryonic
day 12 but then increased during development. This
branched type sialylated N-glycan structure comprised
approximately 2 % of the total N-glycans in the adult
brain. Some N-glycans (containing type 2 antennary)
were found to change their type of sialic acid linkage
from α(2-6)-Gal to α(2-3)-Gal. Thus, the linkages and
expression levels of sialylated N-glycans change dramat-
ically during brain development.
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Sugar chains envelop the vast majority of the cell surface and
are considered to play significant roles in cell-cell and extra-
cellular matrix interactions as mediators and as signal trans-
ducers. Increasing evidence suggests that glycosylation is
critical to various biological functions and requires the coor-
dinated action of glycosyltransferases [1, 2]. Others and we
have studied developmental changes in the gene expression of
sugar chain-metabolizing enzymes and the structure of
glycoconjugates and found that the expression of
glycoconjugates including N-glycans and glycosphingolipids
changes dramatically during development [3, 4], differentia-
tion [5], and oncogenic transformation [6]. However, so far we
have only been able to analyze the structure of N-linked sugar
chains after removal of sialic acid residues due to the com-
plexity of glycosylation analysis.
Sialic acids are widely distributed as terminal sugars
that coat the cell surface and participate in various
biological processes, including cell-cell communications,
cell migration, adhesion, inflammation, immune defense,
and cancer metastasis [7]. In the rodent brain, 40 % of
total N-glycan is sialylated and approximately 10 % of
these N-glycans carry polysialic acids (PSA), which are
partly comprised of PSA on neural cell adhesion mole-
cules (N-CAM) [8]. Growing evidence suggests that
structures containing sialic acid play particularly impor-
tant roles in cell-cell and extracellular matrix interac-
tions [9–12]. Proteins that recognize and bind to a
certain structure of sugar chains are called lectins.
Among the lectins, those that bind to sialic acid-
containing structures are named “siglecs” (sialic acid-
binding immunoglobulin-like lectins), demonstrating the
significance of this type of lectin. Siglecs can recognize
not only the sialic acid residue but also the sugar
residue next to it [13, 14]. They also distinguish the
linkage between sialic acid and the next sugar residue
[15]. Thus, siglecs that bind to α(2-3)-sialic acid are
distinct from those that bind to α(2-6)-sialic acid. The
α(2-3)-sialic acid binding proteins such as CHL1,
NrCAM, and NgCAM, belong to the L1 super-family
and have all been shown to be neurite outgrowth pro-
moters and/or mediators of neuron–glia interactions
[16]. Myelin-associated glycoprotein (MAG), a member
of the siglecs recognizing α(2-3)-sialic acid, is involved
not only in myelin formation, but also in myelin main-
tenance [17]. It has received particular attention because
it enhances in vitro neurite outgrowth at early develop-
mental stages but inhibits neurite outgrowth in adults
[18]. MAG might thereby contribute to a non-conducive
environment for regeneration in the adult mammalian
nervous systems. Therefore, it is extremely important
to determine the structure of sialic acid-containing sugar
chains in the adult brain as well as changes in glyco-
sylation during development to understand the signifi-
cance of interactions between siglecs and sialic acid-
containing sugar chains. Brain ganglioside structures
have been well analyzed and their developmental profile
of expression is known [19, 20]. However, structures of
N-linked sugar chains during brain development remain
poorly understood. Therefore, we aimed to identify
sialylated N-glycans whose expression levels vary dra-
matically during brain development.
In an earlier report, the structure of sialylated N-glycans in
the adult rat brain was thoroughly analyzed and quantified [8].
Sialylated N-glycans were found to carry predominantly α(2-
3)-linked sialic acid in the adult rat brain as compared with
α(2-6)-linked sialic acid [8, 21]. The structures of most of the
sialic acid-containing N-linked sugar chains were also deter-
mined. However, the quantification of each sugar chain was
performed using MALDI-TOF mass spectrometry. Quantifi-
cation of different substances using this method is difficult
since their ionization efficiencies can differ significantly, and
furthermore the developmental profile of sugar chains was not
investigated. Moreover, there was a critical lack of informa-
tion regarding the linkage of sialic acid bound to each N-
linked sugar chain, because permethylation analysis of the
entire set of brain sugar chains was performed without purifi-
cation prior to the linkage analysis.
We have been developing a systematic method to
analyze N-glycan expression patterns present in whole
tissues without glycoprotein purification after removal
of sialic acid residues [22–25]. Here, we report a simple
method to analyze sialic acid-containing N-glycans, and
we systematically analyze expression levels and linkages
of sialylated N-glycans in the developing mouse cere-
bral cortex using this system. This study identified one
sialylated N-glycan having a branched sialic acid struc-
tural feature. This N-glycan contains a sialic acid at-
tached to the N-acetylglucosamine residue of the
Galβ(1-3)-GlcNAc- moiety at the non-reducing end via
an α(2-6)-linkage, with no sialic acid attached to the
galactose residue [Galβ(1-3){NeuAcα(2-6)}GlcNAc-],
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which we termed the 6-sialyl Lewis C structure. This
branched sialylated structure changed its content dynam-
ically during development in the mouse brain, suggest-
ing that N-glycans with 6-sialyl Lewis C plays impor-
tant roles during brain development.
Materials and methods
Materials and chemicals
Anhydrous hydrazine was purchased from Tokyo Chemical
Industry (Tokyo, Japan), 2-aminopyridine was from Kanto
Chemical (Tokyo, Japan), and dimethylamine borane was
from Wako (Osaka, Japan). Graphite carbon columns (GL-
Pak carbograph, Cat. No. 5010–23005) were purchased from
GL Science (Tokyo, Japan). Cellulose cartridge columns were
from Takara Bio (Cat. No. 4404; Otsu, Japan) and GL Science
(Cat. No. 5010–11130). Microgranular cellulose for packed
cellulose columns was from Sigma (St. Louis, MO, USA).
Neuraminidase derived from Arthrobacter ureafaciens was
purchased from Nacalai Tesque (Kyoto, Japan). α2,3-
sialidase, specific for α(2-3)-NeuAc, was from New England
BioLabs (Ipswich, MA, USA). Pyridylaminated (PA)-sugar
chains used as a standard were purchased fromTakara Bio and
Seikagaku Corporation (Tokyo, Japan).
Animals
ICR mice were purchased from Japan SLC (Hamamatsu,
Japan). All experiments were carried out with permission of
the institutional Animal Research Committee of the National
Institute for Physiological Sciences.
Purification and pyridylamination of sugar chains
N-glycan purification and pyridylamination were performed
as described previously [23–25]. Briefly, ICR mice at various
developmental stages (embryonic day 12 (E12), E16, postna-
tal day 0 (P0), P7) or adult (12 weeks (12w)) were sacrificed
and their cerebral cortices were quickly removed and washed
with ice-cold phosphate-buffered saline (PBS). Tissues were
homogenized in a nine-fold volume of acetone using a
polytron homogenizer. After acetone precipitation, samples
were lyophilized before use. Each lyophilized sample (2 mg)
was hydrazinolyzed (100 °C, 10 h). N-glycan purification and
in-columnN-acetylation was performed using graphite carbon
columns. The reducing ends of the liberated glycans were
tagged with the fluorophore 2-aminopyridine to aid detection
via high-performance liquid chromatography (HPLC) analy-
ses. Excess reagents were removed and PA-N-glycans were
purified using cellulose columns. To analyze N-glycans at
each stage, the samples were prepared from more than ten
mice at each developmental stage and three adult mice for
each experiment.
N-glycan analysis and separation by HPLC
To separate neutral-, mono-, di-, tri-, and tetra-sialyl N-gly-
cans, PA-N-glycans were passed through an anion-exchange
column (Mono Q 5/50 GL, GE Healthcare, Little Chalfont,
UK) using HPLC or a Microgranular DE52-packed column
(Whatman, GE Healthcare). Anion-exchange column HPLC
purification was performed at a flow rate of 1.0 ml/min at
room temperature. The mobile phase consisted of solvent A
(distilled water adjusted to pH 9.0 with aqueous ammonia)
and solvent B (0.5 M ammonium acetate titrated to pH 9.0
with aqueous ammonia). Neutral N-glycans were col-
lected in the non-adsorbed fraction. PA-sugar chains
were detected at excitation and emission wavelengths
of 310 nm and 380 nm, respectively (FP-2025 Plus,
Jasco Corporation, Hachioji, Japan).
Sialylated PA-N-glycans were treated with neuraminidase
at 37 °C for 14 h in 50 mM ammonium acetate pH 5.0 to
cleave sialic acids, followed by heating at 100 °C for 5 min
and filtering through a 0.20 μm spin filter (Ultrafree-MC LG,
Millipore, Billerica, MA, USA).
Analyses of neutral PA-N-glycans using HPLC were
performed as described previously [3, 23–26]. Briefly,
PA-tagged N-glycans of varying sizes were separated by
HPLC using a normal-phase (NP)-column (Shodex
Asahipak NH2P-50 4E, 4.6 × 250 mm, Showa Denko
K.K., Tokyo, Japan) at a flow rate of 0.6 ml/min at
30 °C. PA-N-glycans were detected at an excitation
wavelength of 310 nm and an emission wavelength of
380 nm using a fluorescence detector. Each detected
PA-N-glycan was further analyzed by reverse-phase
(RP) HPLC. RP-HPLC was performed on a Develosil
C30-UG-5 column (4.6 × 150 mm, Nomura Chemical,
Seto, Japan) at a flow rate of 0.5 ml/min at 30 °C. PA-
sugar chains were detected at excitation and emission
wavelengths of 320 and 400 nm, respectively. N-glycan
structures were identified by calculating the Mannose-
Unit value from NP-HPLC, and the Glucose-Unit value
from RP-HPLC, as described previously [26, 27], or by
comparison with known standards and sequential
exoglycosidase digestion.
RP-HPLC for purification of sialylated N-glycans was
performed on a Develosil ODS-5 column (4.6 × 250 mm,
Nomura Chemical) at a flow rate of 1.0 ml/min. The column
was equilibrated with 100 mM acetic acid titrated to pH 4.0
with triethylamine containing 0.05 % 1-butanol. After
injecting each sample, the concentration of 1-butanol was
increased linearly to 0.4 % over 90 min. PA-sugar chains were
detected at an excitation wavelength of 320 nm and an emis-
sion wavelength of 400 nm.
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Data quantification and analysis of PA-sugar chains
PA-N-glycans were quantified and analyzed as described pre-
viously [3, 23–26]. HPLC chromatogram data were analyzed
using Unipoint software (Gilson Inc., Middleton, WI, USA),
LC station software (Shimadzu, Kyoto, Japan) and Empower2
software (Waters, Milford, MA, USA).
Matrix assisted laser desorption ionization time-of-flight mass
spectrometry (MALDI/TOF-MS)
The molecular masses of PA-sugar chains and their iso-
baric monosaccharide compositions were determined by
MALDI/TOF-MS. The PA-sugar chains were dissolved in
water. One microliter of matrix solution (10 mg/ml 2,5-
dihydroxybenzoic acid in 30 % acetonitrile) was applied
on the target spot of plate, and 1 microliter of sample
solution was added, and then dried by warm air. MALDI/
TOF mass spectra of the samples were acquired using a
REFREX spectrometer (Bruker-franzen, Germany) in the
positive and reflector mode at an acceleration voltage of
20 kV and delayed ion extraction. Standard PA-sugar
chains were used to achieve a two-point external calibra-
tion for mass assignment of ions. The mass spectra shown
are the sum of at least 30 laser shots.
Exoglycosidase digestion
Purified PA-N-glycans were digested for 3 h at 37 °C using the
following each enzyme: Xanthomonas manihotis β1,3-galac-
tosidase (New England BioLabs), specific for β(1-3)-Gal, in
50 mM sodium acetate pH 4.5, 100 μg/ml BSA; Diplococcus
pneumoniae β-galactosidase (Roche Diagnostics, Basel,
Switzerland), specific for β1,4-Gal, in 50 mM sodium acetate
pH 6.0;α1,3/4-L-fucosidase (Takara Bio), specific forα1,3/4-
Fuc, in 100 mM sodium phosphate buffer pH 6.0; bovine
kidney α1,6-fucosidase (Prozyme, Hayward, CA, USA), spe-
cific for α1-6>1-2/3/4-Fuc, in 100 mM sodium phosphate
buffer pH 6.0. Neuraminidase, specific for α2,3/6/8-NeuAc,
was incubated with PA-N-glycans for 14 h at 37 °C in 50 mM
ammonium acetate pH 5.0.α2,3-sialidase, specific forα(2-3)-
NeuAc, was incubated with PA-N-glycans for 14 h at 37 °C in
50 mM sodium citrate pH 6.0, 100 mM NaCl, 100 μg/ml
BSA. These samples were heated at 100 °C for 5 min. The
reaction mixture was centrifuged at 2,300 × g for 10 min,
followed by filtering through a 0.20 μm spin filter (Ultrafree-
MC LG, Millipore).
SNA lectin affinity chromatography
SNA agarose beads (Vector Laboratory, Burlingame, CA,
USA) were packed into a 50 × 10 mm assist mini-column.
One milliliter of the sample was applied to the SNA column
after it had been equilibrated with buffer A, which consisted of
20 mM Tris–HCl (pH 7.5) containing 0.15 M NaCl, 1 mM
MnCl2, 1 mMCaCl2. Unbound oligosaccharides were washed
away with buffer A, and the bound sugar chains were then
eluted from the column with 0.1 M lactose in buffer A.
Results
Analysis of sialylated N-glycans in mouse cortices
We have previously identified the structures of neutral and
desialylated N-glycans that comprised more than 1 % of the
total N-glycan content in the developing mouse brain [3]. The
present study further identifies the structures of sialylated N-
glycans that are abundantly present in the mouse cortices and
the developmental profile of their content. P0 mouse brains
were acetone precipitated and 2 mg each of dried precipitate
was subjected to hydrazinolysis. They were further processed
for purification and pyridylamination as described in Materials
and Methods. PA-N-glycans from mouse brain were applied to
a Mono Q column, which separates sugar chains according to
their negative charge (Fig. 1a). Fractions corresponding to
neutral N-glycan-containing fraction (N), mono-sialyl N-
glycan-containing fraction (S1), di-sialyl N-glycan-containing
fraction (S2) and so on were isolated (Fig. 1a). Amounts of N-
glycans eluting from the S4 fraction or from fractions contain-
ing more sialic acids were very low compared to those from
other fractions. There is a sharp peak corresponding to
monosulfated N-glycans between S1 and S2. A low peak
between N and S1 was derived from contaminants that were
not removed during N-glycan purification. Over 50 % of the
total N-glycans were confirmed to have a neutral charge. The N
fraction was collected and then N-glycans in the N fraction
were directly applied to NP-HPLC, which revealed that they
were composed primarily of oligomannose-type sugar chains,
which constitute 45.5 % of the total N-linked sugar chains in
the adult mouse cerebral cortex [3]. These highly abundant
high mannose-type sugar chains (M5 to M9) can be detected
on NP-HPLC chromatograms (Fig. 1b).
To characterize the sialylated N-glycans, the fractions (S1,
S2 and S3) were collected separately. The samples were
desialylated with neuraminidase and then applied to a DE52
column. The flow-through fraction was subjected to NP-
HPLC; however, the peaks were still incompletely separated
and could not be identified or quantified at this point (Fig. 1b).
The eluate was therefore collected following the NP-HPLC
into 30 fractions, whichwere subjected to RP-HPLC.We have
improved the separation achieved by NP-HPLC [25] and the
number of fractions was thereby increased from 10 to 30,
improving the resolution of samples. Using this improved
method, two new N-glycans present at a relatively high abun-
dance (more than 0.1 % of total N-glycan content) were
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identified, which were not found in our previous analysis [3];
they have tentatively been named X1 and X2. The structures
of these two sugar chains were determined as described below.
A two-dimensional (2D) map of PA-N-linked sugar chains
expressed in adult mouse brain was constructed using as
indices the mannose units (MU) measured by NP-HPLC and
the glucose units (GU)measured by RP-HPLC. The structures
were identified by exoglycosidase digestion and MALDI/
TOF/MS as follows. Firstly, the molecular masses of the PA-
sugar chains were determined by MALDI/TOF-MS. The X1
composition estimated from the measured mass number was
deoxyHex2Hex5HexNAc4-PA (Table 1). The PA-N-glycan
X1 showed an elution time in MU of 7.8 on NP-HPLC and
in GU of 10.8 on RP-HPLC. The sugar was susceptible to
digestion with α1,6-fucosidase (Fig. 2a (1)). In this case, one
fucose residue was released, and the product was mapped to
the position (GU 9.6, MU 7.1) on the 2D-map. Further diges-
tion was performed with α1,3/4-fucosidase (Fig. 2a (2)),
resulting in the release of one fucose residue. This digested
product was mapped to the position (GU 10.4, MU 6.6),
which co-eluted on RP-HPLCwith the standard PA-N-glycan,
A2G2. The product of β1,4-galactosidase digestion (Fig. 2a
(3)) was further digested withα1,3/4-fucosidase. This product
(GU 12.3, MU 6.0) co-eluted with the standard, A2G1(6)F.
Thus the structure of PA-N-glycan X1 was determined to be
A2G2Fo(6)F (Fig. 2a, structures shown in Table 2).
The X2 composition estimated from the measured mass
number was deoxyHex2Hex5HexNAc5-PA (Table 1). The PA-
N-glycan X2 (GU 21.5, MU 7.9) was digested with β1,4-galac-
tosidase (Fig. 2b (3)). In this case, one galactose residue was
released, and the product was mapped to the position (GU 20.8,
MU 7.2) on the 2D-map. Further digestion was performed with
α1,3/4-fucosidase (Fig. 2b (2)), resulting in the release of one
fucose residue. This digested product wasmapped to the position
(GU 22.3, MU 6.7), which co-eluted on RP-HPLC with the
standard PA-N-glycan, Ga-BA-2. X2 was digested with α1,3/
4-fucosidase. This product (GU 23.0,MU 6.9) co-elutedwith the
standard, G2-BA-2. Thus, the structure of the PA-sugar chain X2
was determined to be A2G2Fo(6)FB (Fig. 2b).
All other peaks whose content was over 0.1 % of the total N-
glycan content had been identified previously [3, 8]. Thus it
became possible to quantify major N-glycans contained in each
Mono Q fraction (N, S1 to S4) and to determine the sialic acid
linkages of each N-glycan. However, since several chromato-
graphic separation steps were employed to separate the sugar
chains, we could not reliably compare the levels of N-glycans
contained in different Mono Q fractions. Thus we developed a
more practical approach for quantitative analysis of sialylated N-
glycans. The PA-sugar chain mixture was treated with neuramin-
idase and then applied to Mono Q HPLC, and the flow-through
fraction was collected. This fraction contains neutral sugar chains
and desialylated sugar chains (N+D fraction). Fig. 3a shows a
differential NP-HPLC pattern obtained from the N+D (solid
line) and N (grey line) fractions of the P0 mouse brain. The
Table 1 Mass analysis of X1 and
X2. *Average mass calculated












X1 2034.31 2011.32 2010.76 deoxyHex2Hex5HexNAc4-
PA
A2G2Fo(6)F
X2 2237.45 2214.46 2213.84 deoxyHex2Hex5HexNAc5-
PA
A2G2Fo(6)FB
Fig. 1 Simple approaches for structural analysis of sialylated N-glycans
using HPLC. aMono Q HPLC chromatogram from the P0 mouse cortex.
N, S1, S2, S3 and S4 indicate the elution positions of neutral, monosialo,
disialo, trisialo and tetrasialo PA-oligosaccharides, respectively. The frac-
tions (N, S1, S2 and S3) were collected separately. b NP-chromatograms
of neutral and desialylated PA-sugar chains from the P0 mouse cerebral
cortex. After fractionation on a Mono Q column, N-glycans in the N
fraction was directly analyzed by NP-HPLC. After N-glycans in the S1,
S2 and S3 fractions were desialylated with neuraminidase, the samples
were analyzed by NP-HPLC. M5-M9 indicate high-mannose type sugar
chains. The bars with X1 and X2 indicate the elution positions of X1 and
X2, respectively. Results are representative of more than six experiments
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amount of sialylated sugar chains can be estimated by comparing
the areas under each peak obtained from the N fraction with that
from the N+D fraction. However, the separation thus achieved
was insufficient, so these fractions were then subjected to RP-
HPLC. Figure 3b shows an RP-HPLC chromatogram of a
fraction indicated by a bar in Fig. 3a; the sialylated component
of each sugar chain is now visible. For example, A2G2 (indicated
by an arrow) was detected only in the N+D fraction, but not in
the N fraction. This indicates that A2G2 was completely
sialylated. On the other hand, a sugar chain indicated by an
arrowhead is equally abundant in the N and N+D fractions,
indicating that this sugar chain is not sialylated at all.
We examined the sialylated proportions of highly abundant
N-glycans in mouse brains (structures shown in Table 2). To
analyze each N-glycan quantitatively, N-glycans were sepa-
rated by a three-dimensional HPLC system using Mono Q,
NP-, and RP-columns. Since high-mannose type N-glycans
are not sialylated [16, 28], highly abundant complex type and
hybrid type N-glycans were investigated [3]. Most sialylated
N-glycans present in the developing and adult mouse cortices
were systematically separated and quantified using the system
(Table 3). The sialylated proportions of A2G2 at E12,
A2G’2F at E12, A2G2Fo(6)FB at E12 and A3G3Fo2F at
E12, E16, P0 and P7 were not examined because the expres-
sion of these N-glycans was not detected, as previously re-
ported [3]. The N-glycan content in the N+D fraction was
subtracted by its content in the N fraction and was termed the
Cα2,3/6/8 value, which represents the neuraminidase sensitive
portion of a given N-glycan. Most N-glycans containing outer
fucose residues (Fo), namely A2G1FoF, Lewis X(a+b)-BA-2,
Lewis X2-BA-2, Lewis X-H4FB, and Lewis X-H5F, had a
Cα2,3/6/8 value of 0, meaning that they did not contain sialic
acid residues (Table 3). These results indicate that the Lewis X
epitope present in the mouse cortex from any developmental
stage is not sialylated. About 70 % of A2G2Fo(6)F and
A2G2Fo(6)FB were sialylated (Table 3); these contain
one Lewis X epitope and one galactose residue at their
non-reducing ends. We speculate that the Gal-containing
antennary of these N-glycans was sialylated. Therefore,
it is likely that developing and adult mouse cortices
contain no sialyl Lewis X moiety.
Analysis of the linkages of sialic acid residue on N-glycans
during brain development
To determine the linkages of sialic acid residues on N-glycans,
an analysis was performed using α2,3-sialidase (specific for
α2,3-NeuAc). PA-N-glycans were treated with α2,3-sialidase
in place of neuraminidase and analyzed as described before,
throughMono QHPLC separation to RP-HPLC. Examples of
HPLC profiles used for further calculations are shown in
Fig. 4. When all of the sialic acid residues are connected to
N-glycans via an α2,3-linkage, the neuraminidase sensitive
portion (Cα2,3/6/8 value) and α2,3-sialidase sensitive portion
(Cα2,3 value) should be the same. Quantification of the α2,3-
sialidase sensitive proportion of the major sialylated N-
glycans is presented in Table 3. From this table the α2,3-
sialidase resistant portion can also be calculated by subtracting
Fig. 2 Structural determination of N-glycans by exoglycosidase diges-
tions. Schemes showing 2D-mapping of desialylated N-glycans after
exoglycosidase treatment. On this map, the horizontal and vertical axes
correspond to GU (RP-HPLC) and MU (NP-HPLC), respectively. Tra-
jectories for enzymatic digestions are indicated by arrows with solid
lines. The numbers of the plotted points indicate the oligosaccharide
structures. The nomenclature of the structures is shown in the footnote.
Composition: H=hexose, N=GlcNAc, F=Fucose. Enzymes: α1,6-
fucosidase (1), α1,3/4-L-fucosidase (2), and β1,4-galactosidase (3) . a
Determination of X1 structure. b Determination of X2 structure
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the Cα2,3 value from the Cα2,3/6/8 value. This difference should
indicate the amount of N-glycans containing sialic acid with
anα2-6/8-linkage. Therefore, it is highly likely that the mouse
brain contains large amounts of N-glycans containing sialic
acid with an α(2-6)-linkage. However, this conclusion
contrasts with a report by Zamze et al. [8] that 3-substituted
galactose is far more abundant than 6-substituted galactose in
the adult rat brain according to a methylation analysis. To
determine whether mouse brain contains an abundant amount
of N-glycans with a NeuAcα(2-6)-Gal- moiety, SNA lectin
Table 2 Structures of N-glycans and their abbreviations. All structures are shown as pyridylaminated (PA-) forms. The nomenclature of oligosaccharide
structures was described in Footnotes and reported previously [3, 26]
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affinity chromatography was performed. The initial PA-sugar
chain mixture from the P0 mouse brain was applied to the
SNA lectin column and the adsorbed fraction was further
subjected toMonoQHPLC analysis. Most of the sugar chains
were recovered in the S1 and S2 fractions (data not shown).
After neuraminidase treatment, the structures of the sugar
chains in these fractions were determined by 2D-HPLC anal-
yses. N-glycans were abundantly present in these fractions,
including A2G2, A2G2F, Ga-BA-2, Gb-BA-2 and G2-BA-2.
These were all type 2 sugar chains containing a Galβ(1-4)-
GlcNAc- structure. Interestingly several N-glycans such as
Ga/b-BA-2, G2-BA-2 and A2G2Fo(6)F contained very
little or no α2,3-sialidase sensitive portions in the E12
mouse brain, but these increased during development
(Table 3), suggesting a switch from α2,6-sialylation to
α2,3-sialylation on the same N-glycan.
Identification of a N-glycan structure containing branched
α2,6-sialic acid residue in the mouse brain
It is known that there are two types of α2,6-sialylated
N-glycans: one attached to the galactose residue at the
non-reducing end (NeuAcα(2-6)-Gal-) and the other to
the GlcNAc residue in the type 1 antennary of N-
glycans [Galβ(1-3){NeuAcα(2-6)}GlcNAc-]. Since there
was only one major type 1 N-glycan (A2G’2F) in the
mouse cortex, we determined the linkage type of sialic
acid residues on A2G’2F in the adult mouse cortex.
A2G’2F has four potential sialylation sites (two on Gal
and two on GlcNAc). After Mono Q HPLC fractionation
and neuraminidase treatment, A2G’2F was recovered pri-
marily from the S2 and S3 fractions (data not shown), thus
A2G’2F generally contains two or three sialic acid residues.
We focused on the S2 fraction for further analysis because
the amount of A2G’2F in the S2 fraction was higher than
that in the S3 fraction. After α2,3-sialidase treatment of the
S2 fraction, A2G’2F was recovered from the S0, S1 and S2
fractions (data not shown), indicating that A2G’2F has two
α2,3-sialidase-sensitive sialic acids, one resistant and one
sensitive sialic acid residue or two α2,3-sialidase-resistant
sialic acids.
The next step was to determine at which position the
α2,3-sialidase-resistant sialic acid residues are attached.
We decided to isolate A2G’2F with two α2,3-sialidase-
resistant sialic acid residues in its sialylated (native)
form. The PA-sugar chain mixture extracted from 12w
mouse brains was subjected to Mono Q HPLC and the
S2 fraction was recovered (Fig. 5a-a). Sugar chains in
this fraction were treated with α2,3-sialidase, subjected
to Mono Q HPLC and the S2 fraction was collected
again (Fig. 5a-b). This fraction should contain only
sugar chains having two α2,3-sialidase-resistant sialic
acid residues. This fraction was separated by RP-
HPLC in the presence of triethylamine (Fig. 5b). There
were some major peaks in this fraction. Each peak was
collected, treated with neuraminidase, and analyzed
using NP- and RP-HPLC by comparison with known
standards. The peak 1 in Fig. 5b was identified as
A2G’2F, thus this sugar chain is the one we desired.
The peak 1 was collected and then digested with β1,3-
galactosidase to determine if the sialic acid is attached
to the terminal galactose residue. After the enzymatic
reaction, the elution time for the sugar chain on RP-
HPLC with triethylamine changed, indicating that at
least one galactose residue had been removed
(Fig. 5c). This product (the peak 2) was analyzed by
Mono Q HPLC and the results indicated it contained 2
sialic acid residues (Supplementary Fig. S1). After neur-
aminidase treatment the galactosidase-reaction product
was analyzed by 2D-HPLC mapping and was found to
be identical to A2G0F (Fig. 6). These results demon-
strate that sialic acids were not attached to the terminal
galactose residues of the sialylated N-glycan. There is
only one possible attachment site for sialic acids other
than galactose, i.e. the 6th position of the GlcNAc
Fig. 3 Practical approaches for quantitative analysis of sialylated N-
glycans using HPLC. Neutral and asialo N-glycans, which were treated
with neuraminidase, were separated and fractionated by Mono Q HPLC.
Fractions were then analyzed by NP-HPLC a and a fraction indicated by
the bar was collected. This fraction was separated by RP-HPLC for
further analysis b. The black line indicates the chromatogram of neutral
and desialylated PA-oligosaccharides derived from the P0 mouse brain
and the gray line indicates that of neutral sugar chains. From the com-
posite image of two chromatograms, sialylated sugar chains can be
calculated as the difference in the peak areas. Arrow indicates the elution
position of A2G2, arrowhead indicates the elution position of
A1G1FoFB. Results are representative of more than six experiments
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residue. Thus, we propose the structure to be the one
presented in Fig. 6. As far as we know, this is the first
report identifying α2,6-sialylated GlcNAc-containing N-
glycans without terminal galactose sialylation in the
brain.
To exclude a possibility of a tandem di-sialyl linkage, α(2-
8)-linked di-sialic acid chains, at the 6th position of GlcNAc,
the di-sialylated N-glycan from the peak S2 in Supplementary
Fig. S1 was treated with β-N-acetylhexosaminidase (Supple-
mentary Fig. S2A). After β-N-acetylhexosaminidase treat-
ment, the sample was analyzed by Mono Q HPLC and the
results indicated it contained 2 sialic acid residues (Supple-
mentary Fig. S2B). The di-sialylated N-glycan from the peak
S2 in Supplementary Fig. S2B was treated with neuramini-
dase. The product was analyzed by 2D-HPLC mapping, NP-
HPLC withMU standards (Supplementary Fig. S2C) and RP-
HPLC with standards (data not shown), and was found to be
identical to A2G0F. These results indicate that di-sialylated
A2G’2F contained two [Galβ(1-3){NeuAcα(2-6)}GlcNAc-]
structures, not α(2-8)-linked di-sialic acid chains.
We examined the expression levels of N-glycans with
the branched sialic acid-containing structure [Galβ(1-
3){NeuAcα(2-6)}GlcNAc-], termed 6-sialyl Lewis C,
in the developing and adult mouse cerebral cortices.
Whereas N-glycans with 6-sialyl Lewis C were barely
detected at E12, their expression level increased during
development, reaching approximately 2 % of the total
Table 3 Proportion of sialic acid-containing N-glycans in developing
and adult cortices. Quantification of the neuraminidase or α2,3-sialidase
sensitive component of each sugar chain from cerebral cortices. Each N-
glycan pool was divided into three aliquots and each aliquot treated with
neuraminidase or α2,3-sialidase, or buffer as a control experiment, re-
spectively. Each aliquot was then applied toMono QHPLC and the flow-
through fraction was obtained. N-glycans were separated and quantified
using NP- and RP-HPLC. Neuraminidase sensitive component (Cα2,3/6/
8)=N-glycan from a neuraminidase treated aliquot - that from a buffer
treated/N-glycan in a neuraminidase treated aliquot × 100. α2,3-sialidase
sensitive component (Cα2,3) was obtained in a similar manner. Values
indicate the percentages of the sialidase-sensitive component. The termi-
nal structures of N-glycans are indicated on the extreme left. N.D., not
detected
No. Abbreviation E12 E16 P0 P7 12W
Cα2,3/6/8 Cα2,3 Cα2,3/6/8 Cα2,3 Cα2,3/6/8 Cα2,3 Cα2,3/6/8 Cα2,3 Cα2,3/6/8 Cα2,3
1 A2G2 N.D. N.D. 100 4.8 99.5 2.9 91.8 13.1 95.0 6.3
2 A2G2F 95.7 25.6 100 11.0 100 21.9 100 29.4 100 15.3
3 A2G’2F N.D. N.D. 91.4 23.4 100 33.6 100 17.1 100 13.8
4 A4G4F 100 44.3 100 38.8 98.6 46.3 100 60.7 100 25.9
5 Ga-BA-2 48.2 <0.1 64.5 18.8 58.0 15.5 54.8 26.6 68.8 28.9
6 Gb-BA-2 34.4 20.5 42.6 25.5 50.3 38.5 45.1 42.5 42.4 35.9
7 G2-BA-2 45.4 <0.1 85.9 3.7 83.5 14.5 68.9 35.5 82.6 34.9
8 A2G1FoF <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
9 A2G2Fo(6)F 76.0 17.6 92.0 39.9 91.1 40.5 90.1 51.7 85.0 54.1
10 A2G2Fo(6)FB N.D. N.D. 73.8 18.0 69.3 27.3 70.3 27.4 84.8 18.1
11 A3G3Fo2F N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D. 92.0 15.1
12 Lewis X(a + b)-BA-2 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
13 Lewis X2-BA-2 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
14 Lewis X-H4FB <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
15 Lewis X-H5F <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
Fig. 4 Schematic drawing of the HPLC chart. The black line indicates
the chromatogram of neutral and desialylated PA-oligosaccharides and
the gray line indicates that of neutral sugar chains. From the composite
images of two chromatograms, sialylated sugar chains can be calculated
as the difference in the peak areas (Cα2,3/6/8 value). Dotted line shows a
chromatogram obtained after α2,3-sialidase treatment of the sample.
α2,3-sialidase sensitive portion (Cα2,3 value) can be obtained from the
difference in the peak areas under the dotted and gray lines
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N-glycan level in the adult as shown in Fig. 7. These
results suggest that N-glycans with 6-sialyl Lewis C
plays important roles during brain development.
Discussion
It is essential to determine the entire structure of the sialylated
sugar chain, including all of the linkages between sugar resi-
dues, to understand roles played by siglecs and sialylated
sugar chains. It is also important to know their expression
levels during development. A previous study by Zamze
et al. [8] reported a comprehensive analysis of sialylated
N-glycans in the adult rat brain. However, several cru-
cial points were missing: 1) Linkages of sialic acids
attached to each N-glycan were not analyzed; 2) Only
adult brains, but not developing brains, were analyzed;
3) Quantification of N-glycans was based on MALDI-
TOF mass spectrometric analysis, thus expression levels
of different sugar chains could not be compared with
each other. To overcome these problems, we analyzed
Fig. 5 Isolation of di-sialylated
A2G’2F a separation by Mono Q
HPLC of N-glycans from 12w
mouse brains. N, S1-S4 indicate
the elution positions of neutral,
monosialo, disialo, trisialo and
tetrasialo PA-N-glycans,
respectively. (a) N-glycans
derived from 12w cerebral cortex
were applied again to Mono Q
HPLC and the S2 fraction
(indicated by oblique lines) was
collected. (b) After sialylated N-
glycans from the S2 fraction in
Fig. 5a-a were treated with α2,3-
sialidase, the sample was applied
again to Mono Q HPLC. The S2
fraction (indicated by oblique
lines) was collected b the α2,3-
sialidase-resistant S2 fraction in
Fig. 5a-b was applied to an ODS
column. There were some major
peaks, and the peak 1 was
identified as sialylated A2G’2F.
The fraction indicated by oblique
lines was collected. c N-glycans
from the peak 1 in Fig. 5b were
treated with β1,3-galactosidase
and applied again to an ODS
column. The peak 2 was collected
for further analysis. Results are
representative of more than three
independent experiments
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developing and adult mouse brains by fluorescently
labeling N-glycans followed by HPLC analysis. Neur-
aminidase and α2,3-sialidase were used to determine the
linkages of the sialic acid attachments. Through our
analysis the entire structure and expression levels of
all N-glycans whose content exceeds 0.1 % of the total
N-glycan content were elucidated.
Expression changes of sialylated N-glycans during mouse
brain development
This study uncovered mainly three types of linkage between
sialic acid and N-glycans: 1) NeuAcα(2-3)-Galβ(1-4)-
GlcNAc-, 2) NeuAcα(2-6)-Galβ(1-4)-GlcNAc-, 3) Galβ(1-
3)-{NeuAcα(2-6)}GlcNAc-. Some of the N-glycans were
found to change their type of sialic acid linkage during brain
development. A good example is Ga-BA-2, which has only
one possible sialic acid attachment site. This sugar chain
harbors no sialic acid attached via an α(2-3)-linkage at E12,
but in the adult about half of the N-glycan harbors a
NeuAcα(2-3)-Gal- moiety (Table 3). Whereas several N-
glycans such as Ga/b-BA-2, G2-BA-2 and A2G2Fo(6)F
contained very little or no α2,3-sialidase sensitive portions
in the E12 mouse brain, these expression levels were in-
creased during brain development. Since α(2-3)- and α(2-
6)-sialic acid moieties are recognized by different siglecs
[13, 14, 29], they would be expected to play distinct roles
during brain development. Siglecs known to be present in the
brain, such as MAG, L1, neurofascin, contactin and many
others recognize the NeuAcα(2-3)-Gal- structure (reviewed in
Kleene and Schachner [16]), and thus the developmental
appearance of NeuAcα(2-3)-Gal- structure should have phys-
iological significance.
We previously reported that the expression level of
A2G’2F is increased during brain development [3].
Here, we showed that the expression level of structure
3), 6-sialyl Lewis C, was increased during development
in the mouse brain (Fig. 7). A2G’2F with 6-sialyl Lewis
C is a branched structure but in the rat brain the same
backbone (A2G’2F) harbors the di-sialyl Lewis C
[NeuAcα(2-3)-Galβ(1-3)-{NeuAcα(2-6)}GlcNAc-] epi-
tope and usually bears 4 sialic acid residues [8]. We
initially suspected that the sialic acid residue attached to
the galactose residue within the Lewis C epitope on
A2G’2F had been artificially removed during our N-
glycan preparation procedure. Therefore, we started
from a standard PA-sugar chain containing the di-sialyl
Lewis C epitope (Takara Bio, PA-sugar chain 025) and
followed the same preparation procedure from
Fig. 6 Identification of the N-glycan with 6-sialyl Lewis C. The pre-
sumed structure of the N-glycan that was isolated as in Fig. 5 is shown in
the upper panel. After β1,3-galactosidase treatment, the galactose-
removed sugar chain was collected (middle panel), which still harbored
two sialic acids as determined by Mono Q HPLC (Supplementary
Fig. S1). Finally, this de-galactosylated sugar chain was treated with
neuraminidase and its structure determined by 2D-HPLC mapping. The
structure turned out to be A2G0F (lower panel)
Fig. 7 The expression of N-glycans with 6-sialyl Lewis C. The relative
abundance of N-linked sugar chains derived from the developing and
adult mouse cerebral cortices (E12, E16, P0, P7 and 12w) containing
Galβ1,3-(NeuAcα2,6-)GlcNAc- is shown
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hydrazinolysis to pyridylamination. The di-sialyl Lewis
C epitope was recovered in a totally intact form (data
not shown), thus this branched structure is not an arti-
fact. We examined tri-sialyl N-glycans in Fig. 5a-a, and
found that A2G’2F with both 6-sialyl Lewis C and di-
sialyl Lewis C (manuscript in preparation). To determine
whether there is a great difference in the structures of
sialyl Lewis C containing N-glycans between rat and
mouse cortices at the type 1 antennary, N-glycan struc-
tures in rat cortices were analyzed using the same
method applied to analyze mouse cortices. Cortices
from both species were found to contain 6-sialyl Lewis
C and di-sialyl Lewis C at similar levels (manuscript in
preparation). Therefore, we concluded that 6-sialyl Lew-
is C is also present in the rat brain, where it should
play an important role during brain development.
Potential roles of 6-sialyl Lewis C
It was reported that some glycoproteins in bovine plasma
possess N-glycans with 6-sialyl Lewis C [30–32]. However,
physiological roles of 6-sialyl Lewis C and siglecs that recog-
nize this motif have not been known yet. A mono-sialyl gan-
glioside containing 6-sialyl Lewis C, Galβ(1-3){NeuAcα(2-
6)}GlcNAcβ(1-3)Galβ(1-4)Glcβ1,1-ceramide; LS-
tetrasaccharide b (LSTb)-ceramide, was reported [33, 34].
LSTb-probes bind to Siglec-7 better than Siglec-9 [35]. Even
though the significance of these in the brain is unknown be-
cause LSTb has only been described in human milk [33, 34], it
is possible that 6-sialyl Lewis C plays important roles with
specific siglecs in the brain. It remains to be determined wheth-
er or not siglecs that bind to the di-sialyl Lewis C epitope or the
6-sialyl Lewis C epitope are distinct from each other. It would
be interesting to examine roles of 6-sialyl Lewis C by using
synthesized and clustered 6-sialyl Lewis C probes [36]. Further
studies are necessary to address these issues.
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